NPI: 1174954234 · PATERSON, NJ 07514 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 11/27/2013
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 11/27/2013 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 4,692 | $350K |
| 2019 | 9,985 | $673K |
| 2020 | 11,860 | $510K |
| 2021 | 14,194 | $469K |
| 2022 | 22,312 | $507K |
| 2023 | 11,129 | $576K |
| 2024 | 6,727 | $473K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 39,069 | 2,912 | $3.33M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 15,147 | 977 | $119K |
| J1270 | Injection, doxercalciferol, 1 mcg | 9,369 | 714 | $33K |
| J1756 | Injection, iron sucrose, 1 mg | 6,964 | 1,165 | $32K |
| A4657 | Syringe, with or without needle, each | 6,449 | 1,630 | $27K |
| 85041 | 630 | 413 | $4K | |
| 85048 | 538 | 361 | $4K | |
| 83970 | 390 | 289 | $3K | |
| 82728 | 222 | 172 | $3K | |
| 83550 | 244 | 182 | $3K | |
| 83540 | 269 | 196 | $3K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,100 | 449 | $37.97 |
| 90674 | 43 | 28 | $22.56 | |
| G0008 | Administration of influenza virus vaccine | 141 | 97 | $6.85 |
| 90662 | 52 | 29 | $0.00 | |
| OP250 | 249 | 14 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 23 | 13 | $0.00 |